Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II first-line intraperitoneal paclitaxel with systemic S-1 and cisplatin in advanced gastric cancer with peritoneal dissemination and ascites
KCT0003607Phase 2Terminated
- Sponsor
- Samyang Biopharmaceuticals Corporation
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel, tegafur, cisplatin in gastric cancer (GC), sponsored by Samyang Biopharmaceuticals Corporation. Started Jun 2019; status: terminated.
02
Drugs
paclitaxeltegafurcisplatin
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on KCT0003607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003607.